Literature DB >> 1448

Defects in the biochemistry of collagen in diseases of connective tissue.

J Uitto, J R Lichtenstein.   

Abstract

The collagens are the major structural glycoproteins of connective tissues. A unique primary structure and a multiplicity of post-translational modification reactions are required for normal fibrillogenesis. The post-translational modifications include hydroxylation of prolyl and lysyl residues, glycosylation, folding of the molecule into triple-helical conformation, proteolytic conversion of precursor procollagen to collagen, and oxidative deamination of certain lysyl and hydroxylysyl residues. Any defect in the normal mechanisms responsible for the synthesis and secretion of collagen molecules or the deposition of these molecules into extracellular fibers could result in abnormal fibrillogenesis; such defects could result in a connective tissue disease. Recently, defects in the regulation of the types of collagen synthesized and in the enzymes involved in the post-translational modifications have been found in heritable diseases of connective tissue. Thus far, the primary heritable disorders of collagen metabolism in man include lysyl hydroxylase deficiency in Ehlers-Danlos syndrome type VI, p-collagen peptidase deficency in Ehlers-Danlos syndrome type VII, decreased synthesis of type III collagen in Ehlers-Danlos syndrome type IV, lysyl oxidase deficency in S-linked cutis laxa and Ehlers-Danlos syndrome type V, and decreased synthesis of type I collagen in osteogenesis imperfecta.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1448     DOI: 10.1111/1523-1747.ep12481404

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  20 in total

Review 1.  The hypoxia-inducible-factor hydroxylases bring fresh air into hypoxia signalling.

Authors:  Edurne Berra; Amandine Ginouvès; Jacques Pouysségur
Journal:  EMBO Rep       Date:  2006-01       Impact factor: 8.807

2.  A preliminary characterization of human cementum collagen.

Authors:  P Christner; P Robinson; C C Clark
Journal:  Calcif Tissue Res       Date:  1977-06-28

3.  Functional role of periostin in development and wound repair: implications for connective tissue disease.

Authors:  Douglas W Hamilton
Journal:  J Cell Commun Signal       Date:  2008-07-20       Impact factor: 5.782

4.  Specific changes in the collagen phenotype of BALB 3T3 cells as a result of transformation by sarcoma viruses or a chemical carcinogen.

Authors:  R I Hata; B Peterkofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

5.  Characterization of the synthesized collagen by mouse L-929 (L-5) cells.

Authors:  S Matsubayashi; H Shinkai; S Sano
Journal:  Arch Dermatol Res       Date:  1977-10-27       Impact factor: 3.017

Review 6.  Diseases of the collagen molecule.

Authors:  C I Levene
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1978

7.  A new variety of spondyloepiphyseal dysplasia characterized by punctate corneal dystrophy and abnormal dermal collagen fibrils.

Authors:  P H Byers; K A Holbrook; J G Hall; P Bornstein; J W Chandler
Journal:  Hum Genet       Date:  1978-01-19       Impact factor: 4.132

8.  Biochemical changes of intervertebral discs in patients with spondylolisthesis or with tears of the posterior annulus fibrosus.

Authors:  S Roberts; H K Beard; J P O'Brien
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

9.  Modulation of collagen production by fibroblasts. Effects of chronic exposure to agonists that increase intracellular cyclic AMP.

Authors:  L E Saltzman; J Moss; R A Berg; B Hom; R G Crystal
Journal:  Biochem J       Date:  1982-04-15       Impact factor: 3.857

10.  Genetics of the connective tissue proteins: assignment of the gene for human type I procollagen to chromosome 17 by analysis of cell hybrids and microcell hybrids.

Authors:  C V Sundar Raj; R L Church; L A Klobutcher; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.